Your session is about to expire
← Back to Search
Exercise Prehabilitation for Liver Cancer
N/A
Recruiting
Led By Mohammed Al-Jumayli, MD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if exercise can help people with liver cancer prepare for surgery better. #Exercise #Cancer #Health
Who is the study for?
This trial is for seniors aged 70 or older who have been diagnosed with bile duct cancer, liver cancer, or liver metastases and are fit enough to exercise. They must be planning to undergo surgery in at least 4 weeks and able to give consent.
What is being tested?
The study is testing an exercise program that includes resistance and aerobic training for senior adults before they go through liver surgery due to hepatobiliary cancers.
What are the potential side effects?
Since the interventions involve physical exercises like resistance and aerobic training, participants may experience muscle soreness, fatigue, or injury related to exercise.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence - Feasibility
Exercise Training Safety
Objective Physical Functioning and Fitness
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tele Health Exercise PrehabilitationExperimental Treatment2 Interventions
Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo surgery (Approximately 2-4 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1230
Aerobic Training
2024
N/A
~880
Find a Location
Who is running the clinical trial?
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
565 Previous Clinical Trials
144,496 Total Patients Enrolled
2 Trials studying Cholangiocarcinoma
49 Patients Enrolled for Cholangiocarcinoma
Mohammed Al-Jumayli, MDPrincipal InvestigatorMoffitt Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to care for myself and move around.My liver cancer is operable and surgery is planned in over 4 weeks.I am 65 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Tele Health Exercise Prehabilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.